Mar 3, 2020, 09:15 AM by Michael Croft

PRINCETON, NJ - Mar 3, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael J

Mar 3, 2020, 08:13 AM by Michael Croft

WESTBURY, NY - Mar 3, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, announced that it is now providing same-day delivery of fresh blood, LEUKOMAX® leukopaks and buffy coats from normal and disease-state donors to cell and gene therapy researchers in the UK

Mar 2, 2020, 14:04 PM by Michael Croft

AUCKLAND, NEW ZEALAND - Mar 3, 2020 - Fast testing during viral outbreaks, such as the current COVID-19, could assist to prevent its spread, saving lives and money

Mar 2, 2020, 14:00 PM by Michael Croft

Mar 2, 2020, 08:36 AM by Michael Croft

WALTHAM, MA, UNITED STATES - Mar 2, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced the findings from its exploratory analysis of “biomarkers of response” (BoR) that predict whether a HER2-positive (Her2+) metastatic breast cancer patient will respond to Herceptin® (trastuzumab) therapy

Mar 2, 2020, 04:52 AM by Michael Croft

BOURNEMOUTH, UK - Mar 2, 2020 - Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEO

Feb 28, 2020, 09:55 AM by Michael Croft

CAMBRIDGE, MA, UNITED STATES - Feb 28, 2020 -  Legit, the leading life sciences collaboration platform, announced today the launch of their new collaboration software geared towards the life sciences

Feb 27, 2020, 22:16 PM by Michael Croft

NEW YORK, NY - Feb 28, 2020 - On February 20, 2020, Alfa Chemistry announced to introduce a wide range of functionalized nanomaterials to meet the increasing demand from their global customers

Feb 27, 2020, 18:25 PM by Michael Croft

Bio-IT World MGI got some attention with its presentation this week of the $100 genome. Among the feedback, a patent infringement suit from Illumina relating to the “CoolMPS” sequencing products.

Feb 27, 2020, 12:32 PM by Michael Croft

BOLOGNA, ITALY AND HUNTINGDON VALLEY, PA - Feb 27, 2020 - Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysis

Feb 27, 2020, 10:10 AM by Michael Croft

Feb 27, 2020, 04:15 AM by Michael Croft

ALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market report

Feb 26, 2020, 14:00 PM by Michael Croft

Bio-IT World  The Pistoia Alliance yesterday released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS). V6 delivers a stable foundation for the collection and exchange of reaction data and empowers the community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. As increased adoption of AI and ML in R&D continues, such industry-wide data standards are essential in the move toward the digitally driven Lab of the Future (LoTF).

Feb 26, 2020, 13:00 PM by Michael Croft

Bio-IT World  Cardiologist Eric Topol, author of the Creative Destruction of Medicine and The Patient Will See You Now has often written about medicine and technology. But Deep Medicine isn’t just about technology.

Feb 25, 2020, 17:16 PM by Michael Croft

SAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutations

Feb 25, 2020, 12:05 PM by Michael Croft

Feb 25, 2020, 10:09 AM by Michael Croft

HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Bank’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors

Feb 25, 2020, 09:15 AM by Michael Croft

BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)

Feb 25, 2020, 08:36 AM by Michael Croft

PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc

Feb 25, 2020, 04:50 AM by Michael Croft

CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies  that have a reduced risk of bleeding compared to current therapies